Webinar Summary – Can We Improve Functioning In Our Patients With Schizophrenia?: Side Effect Burden & Recovery Approach To Informed Decision Making
This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/can-improve-functioning-patients-schizophrenia/.
On September 26, 2018, Dr. Greg Mattingly and Dr. Ralph Aquila convened to discuss how treatment goals balance effective control of symptoms while minimizing side effects for patients living with schizophrenia (SZ). Speakers were paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Greg Mattingly, M.D., is an Associate Clinical Professor at Washington University School of …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.